BIVDA Press Releases


Press Release - BIVDA Responds to new Diagnostics Research Funding & the Life Sciences Innovative Manufacturing Fund Launch

BIVDA, the UK’s leading association for in vitro diagnostic (IVD) technology and innovation, welcomes the £200 million in funding announced by BEIS and DHSC to support critical health research into diagnostics and treatment through enhanced data access and digital clinical trial services. Following on from the Medicines and Diagnostics Manufacturing Transformation Fund, a new £60 million Life Sciences Innovative Manufacturing Fund (LSIMF) will help to broaden the commercial-scale manufacturing base of companies at the “leading-edge of innovation”, whose endeavours lead to improved diagnostic and medical device technologies.


The IVD sector plays an important role in the restart of normal NHS operations, and ambitions to make the UK a global science superpower. However, in order to realise the sector’s full potential in terms of exports and protecting public health, funding for manufacturing must be innovation and automation-oriented.


BIVDA CEO Doris-Ann Williams MBE said:

“Building a diagnostics sector of critical mass requires supportive policy-making and funding allocation. We welcome today’s innovation research investment and the LSIMF from the Government as steps towards boosting the UK’s crucial diagnostic output”.  


For further information, please contact


All Party Parliamentary Group to raise the profile of the UK Life Sciences sector

This week marked the relaunch of the All Party Parliamentary Group (APPG) for Life Sciences.

Read More >

BIVDA Press Release - MHRA authorises exceptional use of COVID-19 self-testing device

BIVDA has issued a Press Release on the MHRA's decision to grant exceptional use authorisat...

Read More >

BIVDA response to Parliament’s vote on the Brexit deal

Doris-Ann Williams, Chief Executive of BIVDA, comments on Parliament’s vote on the Brexit deal

Read More >

BIVDA Press Release - BIVDA Comments on health plans announced in Queen’s Speech

BIVDA Chief Executive Doris-Ann Williams and Chief Operating Officer Helen Dent have commented on th...

Read More >

BIVDA welcomes publication of Accelerated Access Collaborative’s Our Year in Focus Report

Please see below a press release from BIVDA on the publication of the Accelerated Access Collaborati...

Read More >

BIVDA reacts to the Elective Recovery Plan and increased diagnostic procedures

BIVDA welcomes the Secretary of State’s acknowledgement of the importance of diagnostics durin...

Read More >